 |
|
The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee
Korean J Hepatol. 2011;17(3):189-198. Published online 2011 Sep 30 DOI: https://doi.org/10.3350/kjhep.2011.17.3.189
|
|
Citations to this article as recorded by
 Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma
Kuan-Wei Huang, Yu-Tsung Lai, Guann-Jen Chern, Shao-Feng Huang, Chia-Lung Tsai, Yun-Chieh Sung, Cheng-Chin Chiang, Pi-Bei Hwang, Ting-Lun Ho, Rui-Lin Huang, Ting-Yun Shiue, Yunching Chen, Sheng-Kai Wang
Biomacromolecules.2018; 19(6): 2330. CrossRef Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
Jeong Il Yu, Hee Chul Park
World Journal of Gastroenterology.2016; 22(30): 6851. CrossRef 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2015; 16(3): 465. CrossRef Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives
Jan Erik Slotta
World Journal of Hepatology.2015; 7(9): 1168. CrossRef Considerations for Radiation Therapy in Hepatocellular Carcinoma: The Radiation Oncologists' Perspective
Jeong Il Yu, Hee Chul Park
Digestive Diseases.2014; 32(6): 755. CrossRef
|